Drugs News and Research

RSS

Research links intestinal inflammation with systemic chromosome damage

UCLA scientists have linked for the first time intestinal inflammation with systemic chromosome damage in mice, a finding that may lead to the early identification and treatment of human inflammatory disorders, some of which increase risk for several types of cancer.

1 Jun 2009

Marijuana effectiveness as an HIV self-care strategy

Those in the United States living with HIV/AIDS are more likely to use marijuana than those in Kenya, South Africa or Puerto Rica to alleviate their symptoms, according to a new study published in Clinical Nursing Research, published by SAGE.

31 May 2009

Blood-pressure medicine shown to reverse the effects of early-stage liver failure

Newcastle University researchers analysed a small clinical trial of losartan, a drug normally prescribed for hypertension, on 14 patients in Spain, who had Hepatitis C.

31 May 2009

New research sheds light on ways to improve treatment for aggressive breast cancer

Changing the order that chemotherapy drugs are given to breast cancer patients before surgery makes treatment much more effective, according to trial results presented at the American Society of Clinical Oncology (ASCO) conference, today.

31 May 2009

Researchers plan to target immune cells responsible for eluding antiretroviral treatment

Certain human immune cells known as macrophages are composed of hybrid HIV strains that elude treatment and antiretroviral drugs, according to a new study by researchers from the University of Florida and other institutions, the Gainesville Sun reports.

31 May 2009

Miami-Dade, Blue Cross announce low-cost PPO aimed at county's uninsured

Florida's Miami-Dade County and BlueCross BlueShield of Florida on Tuesday announced a new low-cost health plan, called Miami-Dade Blue, aimed at helping the estimated 600,000 uninsured county residents, the Miami Herald reports.

28 May 2009

Warning on athletes’ use of prescription drugs

Athletes could be putting their lives at risk by doping themselves with powerful prescription drugs, a leading academic has warned. Professor Declan Naughton, Professor of Biomolecular Sciences at Kingston University in South West London, cautioned sportsmen and women against trying to improve their performance by taking drugs known as nitrites without clinical supervision.

28 May 2009

Dementia drugs Aricept, Exelon and Reminyl may put some patients at risk

Side effects associated with several commonly-prescribed dementia drugs may be putting elderly Canadians at risk, says Queen's University Geriatrics professor Sudeep Gill.

27 May 2009

New cellular targets for HIV drug development

Focusing HIV drug development on immune cells called macrophages instead of traditionally targeted T cells could bring us closer to eradicating the disease, according to new research from University of Florida and five other institutions.

27 May 2009

1 million California residents travel to Mexico annually for health care, study finds

About one million adults living in California, including 500,000 immigrants, travel to Mexico for health care each year, according to a study published Tuesday in the journal Medical Care, the San Diego Union-Tribune reports.

27 May 2009

Pledges to reduce health care costs, spending growth could violate antitrust laws, lawyers say

U.S. antitrust laws could affect health care industry groups' efforts to work together to rein in health care costs, the New York Times reports (Pear, New York Times, 5/27).

27 May 2009

California Gov. Schwarzenegger's plan to reduce state spending includes cuts to HIV/AIDS services

California Gov. Arnold Schwarzenegger (R) on Tuesday sent state lawmakers a plan to reduce more than $5 billion in spending that includes cuts to HIV/AIDS services, the Los Angeles Times reports (Rothfeld/McGreevy, Los Angeles Times, 5/27).

27 May 2009

FDA grants full approval for Sprycel (dasatinib) for chronic myeloid leukemia

Bristol-Myers Squibb Company has announced that the U.S. Food and Drug Administration (FDA) has granted full approval for Sprycel (dasatinib) for the treatment of adults in all phases of chronic myeloid leukemia (CML) (chronic, accelerated, or myeloid or lymphoid blast phase) with resistance or intolerance to prior therapy including Gleevec (imatinib mesylate).

27 May 2009

New microscopic device reveals cause of blood clots

Australian researchers have discovered a new way that blood clots can form which might explain why current anti-clotting drugs are sometimes ineffective.

26 May 2009

Treating pain with depression

Pain, the most common reason for adults to visit a primary care physician, and depression, the most frequent mental complaint requiring a doctor's appointment, occur together as often as half the time.

26 May 2009

Some small businesses must cut employee health benefits or lay off workers amid global downturn

Small businesses increasingly are eliminating their employee health coverage plans because of rising health care premiums and declining revenue attributed to the current economic recession, the Wall Street Journal reports.

26 May 2009

Cancer drug capecitabine causes patient to lose fingerprints and be detained by U.S. immigration

Immigration officials held a cancer patient for four hours before they allowed him to enter the USA because one of his cancer drugs caused his fingerprints to disappear. His oncologist is now advising all cancer patients who are being treated with the commonly used drug, capecitabine, to carry a doctor's letter with them if they want to travel to the USA.

26 May 2009

Abraxane prolongs survival in metastatic breast cancer

Research from the Northwestern University Feinberg School of Medicine has found that a less toxic, solvent-free chemotherapy drug more effectively prevents the progression of metastatic breast cancer and has fewer side effects than a commonly used solvent-based drug.

26 May 2009

Future cancer care, can we afford it?

When a cancer patient and his or her doctor discuss the value of a treatment option, the conversation usually centers on a consideration of the treatment's medical benefits versus its possible side effects for the patient. Increasingly, however, as the already high costs of cancer care continue to rise, a full view of the patient's welfare must also take into account the economic impact of the treatment on the patient and his or her family.

26 May 2009

Diabetes drug pioglitazone shows potential against multiple sclerosis

A drug currently FDA-approved for use in diabetes shows some protective effects in the brains of patients with relapsing remitting multiple sclerosis, researchers at the University of Illinois at Chicago College of Medicine report in a study currently available online in the Journal of Neuroimmunology.

26 May 2009

Drugs News and Research

Research links intestinal inflammation with systemic chromosome damage

Marijuana effectiveness as an HIV self-care strategy

Blood-pressure medicine shown to reverse the effects of early-stage liver failure

New research sheds light on ways to improve treatment for aggressive breast cancer

Researchers plan to target immune cells responsible for eluding antiretroviral treatment

Miami-Dade, Blue Cross announce low-cost PPO aimed at county's uninsured

Warning on athletes’ use of prescription drugs

Dementia drugs Aricept, Exelon and Reminyl may put some patients at risk

New cellular targets for HIV drug development

1 million California residents travel to Mexico annually for health care, study finds

Pledges to reduce health care costs, spending growth could violate antitrust laws, lawyers say

California Gov. Schwarzenegger's plan to reduce state spending includes cuts to HIV/AIDS services

FDA grants full approval for Sprycel (dasatinib) for chronic myeloid leukemia

New microscopic device reveals cause of blood clots

Treating pain with depression

Some small businesses must cut employee health benefits or lay off workers amid global downturn

Cancer drug capecitabine causes patient to lose fingerprints and be detained by U.S. immigration

Abraxane prolongs survival in metastatic breast cancer

Future cancer care, can we afford it?

Diabetes drug pioglitazone shows potential against multiple sclerosis

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News